Global Tuberculosis Testing Market Finds Encouragement in Growing Healthcare Efforts


Posted June 24, 2016 by MarketTrends

This report on tuberculosis testing studies the current as well as future prospects of the market globally.

 
The global tuberculosis testing market continues to grow as governments and institutions across the globe continue to make efforts to eradicate this deadly communicable disease. Statistics gathered by the WHO state that 9 million people acquired tuberculosis (TB) in 2013 and 1.5 met a fatal end, out of which 360,000 were HIV positive. These figures are declining with each passing year thanks to the increasingly effective diagnosis and treatment options offered to patients. It is estimated that such initiatives were able to save the lives of 37 million tuberculosis patients between 2000 and 2013.

Avail a Free Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2267

Tuberculosis can be broken down into two types, namely active disease, which can transform to multi-drug resistant TB or MDR-TB, and latent disease. Tuberculosis also has a rare form called miliary TB, which occurs when TB infection finds its way to the bloodstream. The priority steps to counter MDR-TB are supreme quality of treatment for drug-susceptible TB to avert MDR-TB, expanding the reach of testing and detection of MDR-TB cases to remote regions, simplifying the access to good healthcare, infection control, and strengthening the political commitment, especially in BRIC nations, which constitute 50% of global TB cases.

The efforts taken by governments, social activists, and several healthcare institutions have translated into positive results. A ripple effect of these efforts can also be seen in the growth of the global tuberculosis testing market.

The factors driving this gigantic growth are the rising number of tuberculosis cases, increasing acceptance of innovative methods for treating tuberculosis, and enhanced molecular and rapid culture diagnostic tests. The serious involvement and dedicated efforts of non-profit healthcare organizations are further boosting the global tuberculosis testing market. Growing tuberculosis cases have also resulted in increased research and development budgets, encouraging manufacturers to launch better testing technologies.

In terms of geography, the report segments the market into Europe, Asia Pacific, North America, and Rest of the World (RoW). Amongst these, Asia Pacific held the largest share in the market in 2013 and was trailed by North America. The reason for the superiority of Asia Pacific is the increasing patient pool, raising the occurrence of numerous diseases within this region, particularly within China and India. On the other hand, North America has a comparatively smaller patient pool; however, the increasing awareness amongst people, proliferation of advanced tuberculosis tests, and the advanced healthcare infrastructure of this region makes it the second largest tuberculosis testing market globally.

According to the report, the prominent players operating in the market are Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Ltd., Hain Lifescience GmbH, bioMérieux SA, Hologic, Inc. QIAGEN, Akonni Biosystems, Inc., Abbott Laboratories, Alere, Inc., Cepheid, Epistem, Plc. and Sanofi, among others.

Browse Full Research Report: http://www.transparencymarketresearch.com/tuberculosis-testing-market.html

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MarketTrends
Website Transparency Market Research
Phone +1-518-618-1030
Business Address State Tower, 90 State Street, Suite 700
Albany, NY 12207 United States
Country United States
Categories Health
Tags global tuberculosis testing market , tuberculosis testing market
Last Updated June 24, 2016